Meticulous Research® recently released a detailed report titled, ‘‘Saudi Arabia Next Generation Sequencing (NGS) Market Size, Share, Forecast, & Trends Analysis by Offering (Sample Preparation, Instruments), Type (SMRT, DNB), Application (Clinical, Research), End User – Forecast to 2031.’ The report projects that the Saudi Arabian NGS market will reach $50 million by 2031, growing at a 10.1% CAGR from 2024 to 2031.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6002

Key Market Drivers

The Saudi Arabian NGS market is fueled by an increase in cancer diagnoses, growing R&D spending by pharmaceutical companies, and expanding genome mapping initiatives. However, high system costs, alternative technologies, and data privacy concerns are hindering market growth.

Opportunities vs. Challenges

The growing adoption of NGS in hospitals and research labs, alongside government support for large-scale sequencing projects, opens up promising opportunities. However, the market still faces challenges such as a lack of skilled professionals, data interpretation difficulties, and the need for standardized regulations.

Offering Segment Insights

In 2024, consumables are expected to hold 62.6% of the Saudi NGS market, the largest share among offerings. These include sample preparation and sequencing consumables, with library preparation and target enrichment consumables accounting for 45% of the segment. These consumables are vital for streamlining sequencing processes, making them indispensable in both clinical and research settings.

Sequencing Type: Targeted Genome Sequencing

Targeted genome sequencing will dominate in 2024 due to its ability to minimize irrelevant genetic data and significantly reduce costs. This technology's precision also makes it a critical tool in gene-drug research, leading to its widespread adoption in Saudi Arabia.

Research Segment Leads Applications

The research segment is projected to account for 56.9% of the market by 2024, with cancer research holding a 49.4% share within this category. The increasing incidence of cancer and the demand for personalized therapies are driving the widespread use of NGS in research settings.

End Users: Hospitals and Labs Dominate

Hospitals and diagnostic labs will be the largest end users of NGS technologies by 2024, driven by declining sequencing costs and government initiatives supporting local genetic testing under the Vision 2030 plan. This support is expected to drive further growth in clinical diagnostics.

Quick Buy : https://www.meticulousresearch.com/Checkout/38511411

Key Players:

Some of the key players operating in Saudi Arabia NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Beijing Genomics Institute (BGI) (China), Bio-Rad Laboratories, Inc. (U.S.), and 10x Genomics, Inc. (U.S.).

Key Questions Answered in the Report-

• What is the value of revenue generated by the sale of NGS instruments, consumables, and software’s in Saudi Arabia?
• At what rate is the demand for NGS offerings projected to grow for the next five to seven years?
• What is the historical market size and growth rate for Saudi Arabia NGS market?
• What are the major factors impacting the growth of Saudi Arabia NGS market?
• What are the major opportunities for existing players and new entrants in the market?
• Which offering and end user segments create major traction for the manufacturers in this market?
• What are the key trends in this market?
• Who are the major players in Saudi Arabia NGS market? What are their specific product offerings in this market?
• What recent developments have taken place in Saudi Arabia NGS market? What impact have these strategic developments created on the market?

Browse in Depth : https://www.meticulousresearch.com/product/saudi-arabia-ngs-market-6002

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research